Nicaise Claude has filed 15 insider transactions across 3 companies since June 2023.
Most recent transaction: a tax payment of 6780 shares of Sarepta Therapeutics, Inc. ($SRPT) on January 29, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | F | Common Stock | 6780 | $21.23 | 31,532.0000 | 100,237,000 | 17.70% | 0.01% |
| Jan. 29, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | M | Common Stock | 10500 | $13.71 | 38,312.0000 | 100,237,000 | 37.75% | 0.01% |
| Jan. 29, 2026 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | M | Stock Option (right to buy) | 10500 | $0.00 | 0.0000 | 100,237,000 | 100.00% | 0.01% |
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | Nicaise Claude | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| May 23, 2025 | FILANA THERAPEUTICS, INC. | $FLNA | Nicaise Claude | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| March 12, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | M | Common Stock | 9746 | $25.18 | 30,303.0000 | 107,875,000 | 47.41% | 0.01% |
| March 12, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | S | Common Stock | 2491 | $99.64 | 27,812.0000 | 107,875,000 | 8.22% | 0.00% |
| March 12, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | M | Stock Options (right to buy) | 9746 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.01% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | A | Stock Options (right to buy) | 4792 | $0.00 | 20,557.0000 | 107,875,000 | 30.40% | 0.00% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | A | Common Stock | 2383 | $0.00 | 20,557.0000 | 107,875,000 | 13.11% | 0.00% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | Nicaise Claude | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| May 9, 2024 | FILANA THERAPEUTICS, INC. | $FLNA | Nicaise Claude | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | A | Common Stock | 1846 | $0.00 | 18,174.0000 | 92,398,000 | 11.31% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Nicaise Claude | Not found | A | Stock Option (right to buy) | 3679 | $0.00 | 3,679.0000 | 92,398,000 | 9999.99% | 0.00% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | Nicaise Claude | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |